In the context of the European Biotechnology Week
Personalised Medicine Conference 2020 – 5th edition
Tuesday (September 29) and Wednesday (September 30) - Online Event
The Centre for Innovation in Medicine organised the fifth edition of the Conference on Personalised Medicine. It took place virtually via Zoom.
The Conference was planned in the context of the European Biotechnology Week. EuropaBio was the event partner. The event gathered representatives of the authorities, academia, professional societies, patient associations and industry.
Our main sessions evolved around discussions on building resilient healthcare systems.
**********
*******
We also invited two special guests: Eric Green, director of the National Human Genome Research Institute and Benedikt Westphalen, Ludwig-Maximilians-University of Munich. They discussed the main topics of their work.
"What I mean by genomic medicine is this medical discipline, in full swing, which aims to use information about the genome of patients in the planning of therapeutic conduct, not treating patients based on the general presentation of a disease, which leads to a general therapeutic approach, universally valid. On the contrary, genomics helps us recognize that each patient is slightly different, and if we can cultivate data about these differences, then we can guide treatment” said Dr. Eric Green during the special session ”20 years after Human Genome Project”
You can watch it here or read a summary of his presentation here.
**********
*******
"Precision oncology is like a puzzle in which the pieces are represented by oncogenes. Currently, we have all the pieces together, so we have a duty to fit them, so that patients can benefit from the full potential of precision oncology” said Dr. Benedikt Westphalen during the special session ”Comprehensive Genomic Profiling in Clinical Practice”.
You can watch it here or read a summary of his presentation here.
The Plenary Session of the conference began September 30, with the Opening Session - key messages delivered by Marius Geantă, President Centre for Innovation in Medicine and Diana Păun, Presidential Adviser - Department of Public Health.
"More than ever, in 2020 we are talking about the benefits of biotechnology, although we may not be fully aware that we are doing this. At the heart of the laboratory fight against the Covid-19 pandemic is biotechnology. The basis of rt-PCR diagnostic tests for SARS-CoV-2 is molecular biology, as vaccines in various stages of development are based on biotechnology, being biological products. Therefore, there is no better context to discuss the benefits of biotechnology than this year" - Dr. Marius Geantă.
**********
*******
It continued with Plenary lectures - “Building resilient healthcare systems”, delivered by Bogi Eliasen, Director of Health, Institute for Future Studies Copenhagen, Nick Guldemond, Leiden University Medical Center, Professor Integrated Care & Technology and Henrique Martins, former coordinator of e-Health Network, President Board of Shared Services of the Ministry of Health, Portugal.
You can watch it here.
